Press Releases

Date	Title	Company
30-Nov-2023	Global Unstable Angina Therapeutics Market will experience a 5% CAGR, hitting a value of US$ 6.6 Billion by 2033 \| FMI	MARKITWIRED
30-Nov-2023	Global Urinary Retention Therapeutics Industry is projected to hit a remarkable US$ 7.5 billion by 2033, based on data from the FMI study	MARKITWIRED
30-Nov-2023	Global Healthcare Digital Experience Platform Industry, as projected by FMI, aims to achieve a CAGR of 15%, reaching US$ 1.2 Billion by 2033	MARKITWIRED
30-Nov-2023	Formycon and Fresenius Kabi announce File Acceptance for FYB202, a biosimilar candidate to Stelara® (ustekinumab), by the U.S. Food and Drug Administration	Formycon AG
30-Nov-2023	Global Retinal Vein Occlusion Treatment Industry is poised to grow at 5.9% CAGR by 2033, attributing the surge to escalating incidences of CRVO and BRVO \| FMI	MARKITWIRED
30-Nov-2023	Global Portal Hypertension Management Industry is set to experience noteworthy growth, projecting a value of US$ 4.97 Billion by 2033 \| FMI	MARKITWIRED
30-Nov-2023	Global Optic Atrophy Management Industry Field may grow at a 4.9% CAGR, reaching US$ 15.63 Billion by 2033 \| FMI	MARKITWIRED
30-Nov-2023	Global Hospital-Acquired Infection Control Industry foresees a staggering growth, anticipated to hit US$ 12.7 Billion by 2033, boasting a 7% CAGR as per FMI	MARKITWIRED
30-Nov-2023	Global Monkeypox Treatment Industry, as projected by FMI, is set for significant growth, aiming at US$ 249 Million by 2033	MARKITWIRED
30-Nov-2023	Global Nasal Polyposis Treatment Market is on track for a 6.7% CAGR surge, guided by progressive strategies per FMI’s analysis	MARKITWIRED
30-Nov-2023	Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc.	Evolva Holding SA
29-Nov-2023	Qnovia, Inc. announces positive results from first-in-human pharmacokinetic and safety study of lead asset QN-01, a prescription inhaled smoking cessation therapy	Qnovia
29-Nov-2023	Medacta further expands in Rancate, Switzerland, doubling its production capability to support the future growth	Medacta Group SA
29-Nov-2023	PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia	PureTech
29-Nov-2023	Oxford BioTherapeutics Announces Partner Boehringer Ingelheim Received U.S. FDA Fast Track Designation for BI 764532 for the Potential Treatment of Advanced or Metastatic Large-Cell Neuroendocrine Carcinoma of the Lung	Oxford BioTherapeutics
29-Nov-2023	Stanhope and Cadillac Fairview appoint Morgan Lovell to build new lab space at White City Place for life sciences companies	Stanhope and Cadillac Fairview
29-Nov-2023	Almac Discovery and Queen’s University launch state-of-the-art Chemoproteomics facility in Belfast	Almac Discovery and Queen’s University
29-Nov-2023	Spexis Provides Update Regarding Debt-Restructuring Moratorium	Spexis AG
29-Nov-2023	GILEAD SCIENCES AWARDS OVER US$1.5 MILLION TO STRENGTHEN SUPPORT FOR COMMUNITY-LED HIV PROJECTS IN ASIA PACIFIC	GILEAD SCIENCES
29-Nov-2023	Nanologica Receives Order of Purification Media Worth Approx. MSEK 3.6	Nanologica